Pradaxa Capsules

Pradaxa, known generically as dabigatran etexilate, is a prominent oral anticoagulant medication used to prevent strokes and blood clots. The brand was developed and is owned by Boehringer Ingelheim, a leading global pharmaceutical company.

Manufacturing of Pradaxa primarily takes place at Boehringer Ingelheim's sophisticated production facilities in Germany, particularly in Ingelheim am Rhein and Biberach, though secondary packaging and distribution may occur across their global network.

Boehringer Ingelheim remains an independent, family-owned company headquartered in Germany. As one of the world's largest pharmaceutical companies, it focuses on research and development for human pharmaceuticals and animal health. The brand ownership is direct, with no complex corporate layers intervening in its stewardship.